QA: Unicycive Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001766140_2024_Unicycive_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001766140, Unicycive Therapeutics Inc

  xvar xval
0 AssetsCurrent 13,399,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 26,000
3 remainder_Assets 766,000
4 LiabilitiesCurrent 17,534,000
5 LiabilitiesNoncurrent 466,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,547,000
9 ResearchAndDevelopmentExpense 12,902,000
10 remainder_Expenses 0
11 remainder_Revenues 675,000
12 remainder_NetIncome -9,770,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 14,191,000
1 Liabilities 18,000,000
2 Expenses 21,449,000
3 Revenues 675,000
4 StockholdersEquity -3,809,000
5 NetIncome -30,544,000
6 ComprehensiveNetIncome -30,544,000
7 BaseVar 32,042,500
8 EconomicCapitalRatiobeforeLimitedLiability -2.41
9 EconomicCapitalRatio 0.885

Edgar->Model Mapping

Feature Distribution

Change over Time